9/30/2022 8:07:09 AM
Teva Reaches Agreement With Georgia To Settle The State's Price Fixing Claims
9/8/2022 1:50:38 AM
Teva Says Studies Show Effectiveness Of AJOVY For Treatment Of Migraine In Patients With Co-morbid Depression
8/29/2022 2:04:15 AM
Teva : EC Grants Marketing Authorization For Ranivisio, Biosimilar To Lucentis, For Age-related Macular Degeneration
7/26/2022 5:03:00 PM
Teva Loss/share $0.21 Vs. Profit $0.19 Year Ago
7/12/2022 10:33:36 AM
Teva Reaches Agreement With San Francisco To Settle Opioid-Related Claims
7/1/2022 8:43:45 AM
Teva Appoints Eric Hughes As EVP, Global R&D And Chief Medical
Office
6/9/2022 7:47:59 AM
Teva To Present Latest Data On AJOVY Injection At 2022 American Headache Society Annual Meeting
5/25/2022 9:40:52 AM
Teva Reaches Agreement With West Virginia To Settle Opioid-Related
Claims